Provides medical devices for the treatment of structural heart diseases
Minneapolis, MN
NASDAQ: ATSI
Contact: Marty Sutter
Acquisition
Acquired by: Medtronic
Exit date: April 29, 2010
![]()
Rapidly growing Latin American specialty pharma company
Bogota, Colombia
Contact: Toby Sykes
Related News
Lured by Rising Healthcare Demand, Essex Woodlands Enters Latin America
Leading orthopedic biologics company
Durham, NC
Contact: Marty Sutter
Related News
Essex Woodlands Announces Launch of Bioventus, a Strategic Partnership with Smith & Nephew
Develops and manages freestanding outpatient clinics focused on the diagnosis, treatment, and management of chronic airway diseases.
Nashville, TN
Contact: Tamara Elias
Related News
BreatheAmerica Secures Series B Financing Totaling $22M
Engineers and develops therapeutic protease products
South San Francisco, CA
Contact: Jeff Himawan
Related News
Develops complete human genome sequencing and analysis
Mountain View, CA
NASDAQ: GNOM
Contact: Tom Caskey
IPO
Exit date: November 11, 2010
Related News
Scientists Report New Method of Whole-Genome Sequencing
Develops and manufactures minimally invasive treatments for vascular diseases
Irvine, CA
NASDAQ: ELGX
Contact: Guido J. Neels
Related News
Endologix Reports 27% and 25% Revenue Growth for the Full Year and Fourth Quarter 2012
Develops innovative device technology and treatment to address the unmet needs of ENT physicians and their patients
Maple Grove, MN
Contact: Guido J. Neels
Related News
Entellus Medical Inc. Completes Series E Financing Totaling $35 Million
Provides enterprise-level Web-based technologies for commercial, Medicare and Medicaid lines of business
Southborough, MA
Contact: Steve Wiggins
Related News
Essex Woodlands Investment in ikaSystems Supports Rapid Growth
Develops a novel, non-invasive technology for the treatment of hypertension (HTN)
Palo Alto, CA
Contact:
Related News
Kona Medical Raises $30M in “C” Round of Financing
Develops drug candidates targeting indications in ophthalmology, inflammation and oncology, with a lead DARPin in clinical Phase I/IIa
Zurich-Schlieren, Switzerland
Contact: Petri Vainio
Related News
Allergan and Molecular Partners Enter into an Exclusive Alliance
Develops, manufactures, acquires and markets dermatology products
Cumberland, Rhode Island
Contact: Immanuel Thangaraj
Related News
PreCision Dermatology Forms with Onset Therapeutics as Core Commercial and Technology Base
Develops instrumentation systems, software and assay products that drive discoveries in fields ranging from fundamental protein research to biomarker discovery and personalized medicine
Santa Clara, CA
Contact: Ron Eastman
Related News
ProteinSimple Reinvents the Western Blot
Develops the Lens Transformation Technology to allow eye care specialists to produce high quality, premium ophthalmic lenses
Alpharetta, GA
Contact: Marty Sutter
Related News
QSpex Technologies Secures Approximately $20.5 Million in Series D Funding; Appoints New Director
Develops and commercializes therapeutic products for treating chronic disease and age-related changes to skin and soft tissue
Newark, CA
Contact: Ron Eastman
Formerly Known As: Essentia BioSystems Inc.
Related News
Revance Therapeutics Regains All Worldwide Rights to its Botulinum Toxin Products
Develops a method to produce antigen-specific human polyclonal antibody preparations
Lyngby, Denmark
Contact: Jeff Himawan
Related News
Symphogen Grants Exclusive Worldwide License of Phase II Oncology Drug Candidate Sym004 to Merck KGa
Develops an office-based medical device to treat dry eye syndrome
Morrisville, NC
Contact: Immanuel Thangaraj
Related News
TearScience®, Inc. Secures $44.5 Million to Commercialize Breakthrough Treatment for Dry Eye
Develops pet medicines in pain management, anti-allergy and parasiticides that can provide superior convenience and greater compliance than traditional products
Yardley, PA
Contact: Scott Barry
Acquisition
Acquired by: Perrigo
Exit date: February 01, 2013
Related News
FidoPharm and the ASPCA Team Up to Launch New PetArmor Over-the-Counter Flea and Tick Treatment
Acquires, develops and markets prescription pharmaceutical products to treat pain and related conditions
San Diego, CA
Contact: Scott Barry
Acquisition
Acquired by: Shionogi
Exit date: July 18, 2011
![]()
Related News
Targets medical device growth equity acquisitions
Park City, UT
Contact: Guido J. Neels
Related News
Globus Medical Appoints Daniel Lemaitre to Its Board of Directors




